Literature DB >> 12780407

Amniotic membrane as support for human retinal pigment epithelium (RPE) cell growth.

Carmen Capeáns1, Antonio Piñeiro, María Pardo, Catalina Sueiro-López, María José Blanco, Fernando Domínguez, Manuel Sánchez-Salorio.   

Abstract

PURPOSE: The aim of this work was to culture human retinal pigment epithelium (hRPE) cells over human amniotic membrane (hAM). Human AM was studied for its viability as an adequate support for transplantation of an hRPE cell monolayer with preserved cell polarity to the subretinal space.
METHODS: Human AM was obtained from pregnant women during caesarean section. The hAM was sectioned and the pieces were fixed to culture dishes. Human RPE cells were cultured from adult corneal donors and were seeded over hAM. Phase-contrast photographs were obtained. Selected specimens were processed by transmission electronic microscopy (TEM).
RESULTS: The attachment and growth of hRPE cells over hAM was observed. Human RPE cells constituted tight colonies that maintained epithelial phenotype. Using TEM, we identified a monolayer of hRPE cells, with cuboidal to spheroidal morphology. These cells showed integration with the substrate and cell-cell contacts were detected.
CONCLUSION: Amniotic membrane may be a suitable substrate for hRPE growth. Further studies are required in order to determine the viability of hRPE on hAM in the subretinal space.

Entities:  

Mesh:

Year:  2003        PMID: 12780407     DOI: 10.1034/j.1600-0420.2003.00076.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  13 in total

1.  [Preparation of the amniotic membrane with the waterjet].

Authors:  P Schreier; J Darmann; C Jürgens; R Schlüter; J Giebel; F Tost
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

Review 2.  A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.

Authors:  Sara Royce Hynes; Erin B Lavik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-19       Impact factor: 3.117

Review 3.  Nanofiber Scaffold-Based Tissue-Engineered Retinal Pigment Epithelium to Treat Degenerative Eye Diseases.

Authors:  Nathan A Hotaling; Vladimir Khristov; Qin Wan; Ruchi Sharma; Balendu Shekhar Jha; Mostafa Lotfi; Arvydas Maminishkis; Carl G Simon; Kapil Bharti
Journal:  J Ocul Pharmacol Ther       Date:  2016-04-25       Impact factor: 2.671

4.  Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue.

Authors:  Balendu Shekhar Jha; Kapil Bharti
Journal:  Curr Stem Cell Rep       Date:  2015-06

5.  Establishment of a human in vitro model of the outer blood-retinal barrier.

Authors:  R D Hamilton; A J Foss; L Leach
Journal:  J Anat       Date:  2007-10-08       Impact factor: 2.610

6.  Engineering Transplantation-suitable Retinal Pigment Epithelium Tissue Derived from Human Embryonic Stem Cells.

Authors:  Karim Ben M'Barek; Walter Habeler; Alexandra Plancheron; Mohamed Jarraya; Olivier Goureau; Christelle Monville
Journal:  J Vis Exp       Date:  2018-09-06       Impact factor: 1.355

7.  Inner limiting membrane as membranous support in RPE sheet-transplantation.

Authors:  Julia Beutel; Lena Greulich; Matthias Lüke; Focke Ziemssen; Peter Szurman; Karl-Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-07       Impact factor: 3.117

Review 8.  Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.

Authors:  P Fernández-Robredo; A Sancho; S Johnen; S Recalde; N Gama; G Thumann; J Groll; A García-Layana
Journal:  J Ophthalmol       Date:  2014-01-14       Impact factor: 1.909

Review 9.  Scaffolds for retinal pigment epithelial cell transplantation in age-related macular degeneration.

Authors:  Corina E White; Ronke M Olabisi
Journal:  J Tissue Eng       Date:  2017-07-21       Impact factor: 7.813

Review 10.  Refractory full thickness macular hole: current surgical management.

Authors:  Rino Frisina; Irene Gius; Luigi Tozzi; Edoardo Midena
Journal:  Eye (Lond)       Date:  2021-01-21       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.